ZYTIGA 250 mg tablets, ZYTIGA 500 mg film-coated tablets, Apalutamide placebo, JNJ-56021927, PREDNISONE, -
ARN-509-003
Phase 3 small_molecule active
Quick answer
ZYTIGA 250 mg tablets, ZYTIGA 500 mg film-coated tablets, Apalutamide placebo, JNJ-56021927, PREDNISONE, - for Castration-Resistant Prostate Cancer is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Castration-Resistant Prostate Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active